The latest closing stock price for Karyopharm Therapeutics as of February 21, 2025 is 0.60.
An investor who bought $1,000 worth of Karyopharm Therapeutics stock at the IPO in 2013 would have $-963 today, roughly -1 times their original investment - a -25.85% compound annual growth rate over 11 years.
The all-time high Karyopharm Therapeutics stock closing price was 47.12 on June 13, 2014.
The Karyopharm Therapeutics 52-week high stock price is 1.70, which is 183.3% above the current share price.
The Karyopharm Therapeutics 52-week low stock price is 0.53, which is 11.7% below the current share price.
The average Karyopharm Therapeutics stock price for the last 52 weeks is 0.92.
An investor who bought $1,000 worth of Karyopharm Therapeutics stock at the IPO in 2013 would have $-963 today, roughly -1 times their original investment - a -25.85% compound annual growth rate over 11 years.
The all-time high Karyopharm Therapeutics stock closing price was 47.12 on June 13, 2014.
The Karyopharm Therapeutics 52-week high stock price is 1.70, which is 183.3% above the current share price.
The Karyopharm Therapeutics 52-week low stock price is 0.53, which is 11.7% below the current share price.
The average Karyopharm Therapeutics stock price for the last 52 weeks is 0.92.